Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

NCT ID: NCT06492291

Last Updated: 2025-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

3000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-05

Study Completion Date

2028-10-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an extension study to evaluate the longer-term safety and efficacy of enlicitide decanoate in adults with hypercholesterolemia who completed either study MK-0616-013 (NCT05952856), study MK-0616-017 (NCT05952869), or study MK-0616-018 (NCT06450366).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercholesterolemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enlicitide Decanoate

Participants will receive 20 mg of enlicitide decanoate orally once daily (QD)

Group Type EXPERIMENTAL

Enlicitide Decanoate

Intervention Type DRUG

Oral tablet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enlicitide Decanoate

Oral tablet

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MK-0616 Enlicitide

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has completed an enlicitide decanoate (also known as enlictide and MK-0616) parent study \[MK-0616-013 (NCT05952856), MK-0616-017 (NCT05952869), and MK-0616-018 (NCT06450366)\] per protocol (including the final assessments/procedures of their parent study)
* Had an overall study intervention compliance ≥80% while participating in their parent study

Exclusion Criteria

* Has discontinued study intervention in their parent study
* Has an ongoing serious adverse event considered related to study intervention by the investigator in the parent study
* Is planning to begin treatment with a nonstudy protein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) while enrolled in the study
* Is currently participating in an interventional clinical study other than an enlicitide decanoate parent study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Director

Role: STUDY_DIRECTOR

Merck Sharp & Dohme LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alliance for Multispecialty Research, LLC ( Site 0027)

Daphne, Alabama, United States

Site Status

G&L Research ( Site 0035)

Foley, Alabama, United States

Site Status

Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0048)

Phoenix, Arizona, United States

Site Status

National Heart Institute-Research ( Site 0029)

Beverly Hills, California, United States

Site Status

Clinical Trials Research ( Site 0054)

Sacramento, California, United States

Site Status

Velocity Clinical Research, Banning ( Site 0023)

San Bernardino, California, United States

Site Status

Emerson Clinical Research Institute ( Site 0017)

Washington D.C., District of Columbia, United States

Site Status

Excel Medical Clinical Trials ( Site 0010)

Boca Raton, Florida, United States

Site Status

Alliance for Multispecialty Research, LLC ( Site 0037)

Doral, Florida, United States

Site Status

Alliance for Multispecialty Research, LLC ( Site 0056)

Fort Myers, Florida, United States

Site Status

Velocity Clinical Research, Hallandale Beach ( Site 0053)

Hallandale, Florida, United States

Site Status

Jacksonville Center for Clinical Research ( Site 0025)

Jacksonville, Florida, United States

Site Status

South Broward Research ( Site 0012)

Miramar, Florida, United States

Site Status

Progressive Medical Research ( Site 0033)

Port Orange, Florida, United States

Site Status

Clinical Research Trials of Florida ( Site 0006)

Tampa, Florida, United States

Site Status

Clinical Site Partners, LLC dba Flourish Research ( Site 0004)

Winter Park, Florida, United States

Site Status

East Coast Institute for Research, LLC ( Site 0020)

Macon, Georgia, United States

Site Status

Healthcare Research Network - Chicago ( Site 0051)

Flossmoor, Illinois, United States

Site Status

Synexus Clinical Research US - Evansville ( Site 0005)

Evansville, Indiana, United States

Site Status

Midwest Institute For Clinical Research ( Site 0052)

Indianapolis, Indiana, United States

Site Status

Alliance for Multispecialty Research, LLC ( Site 0001)

Lexington, Kentucky, United States

Site Status

L-MARC Research Center ( Site 0011)

Louisville, Kentucky, United States

Site Status

Velocity Clinical Research, Covington ( Site 0026)

Covington, Louisiana, United States

Site Status

Velocity Clinical Research Rockville ( Site 0022)

Rockville, Maryland, United States

Site Status

Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0018)

Troy, Michigan, United States

Site Status

Velocity Clinical Research, Gulfport ( Site 0032)

Gulfport, Mississippi, United States

Site Status

Healthcare Research Network - St. Louis ( Site 0040)

Hazelwood, Missouri, United States

Site Status

Velocity Clinical Research at The Pioneer Heart Institute, Lincoln ( Site 0031)

Lincoln, Nebraska, United States

Site Status

Jubilee Clinical Research ( Site 0049)

Las Vegas, Nevada, United States

Site Status

AB Clinical Trials ( Site 0002)

Las Vegas, Nevada, United States

Site Status

New Mexico Clinical Research & Osteoporosis Center ( Site 0043)

Albuquerque, New Mexico, United States

Site Status

Velocity Clinical Research, Syracuse ( Site 0014)

East Syracuse, New York, United States

Site Status

Icahn School of Medicine at Mount Sinai-Cardiology ( Site 0042)

New York, New York, United States

Site Status

Lillestol Research ( Site 0030)

Fargo, North Dakota, United States

Site Status

altoona center for clinical research ( Site 0024)

Duncansville, Pennsylvania, United States

Site Status

Cardiology Consultants of Philadelphia Yardley ( Site 0021)

Yardley, Pennsylvania, United States

Site Status

Velocity Clinical Research, Anderson ( Site 0015)

Anderson, South Carolina, United States

Site Status

Piedmont Research Partners ( Site 0045)

Fort Mill, South Carolina, United States

Site Status

Coastal Carolina Research Center ( Site 0055)

North Charleston, South Carolina, United States

Site Status

Monument Health Clinical Research, a department of Monument -Monument Health Clinical Research, a d ( Site 0038)

Rapid City, South Dakota, United States

Site Status

Holston Medical Group ( Site 0034)

Kingsport, Tennessee, United States

Site Status

Alliance for Multispecialty Research, LLC ( Site 0050)

Knoxville, Tennessee, United States

Site Status

Velocity Clinical Research, Dallas ( Site 0028)

Dallas, Texas, United States

Site Status

Center for Cardiometabolic Disease Prevention/Baylor College of Medicine ( Site 0009)

Houston, Texas, United States

Site Status

Clinical Trials of Texas, LLC ( Site 0016)

San Antonio, Texas, United States

Site Status

Synexus Clinical Research US, Inc. ( Site 0003)

Salt Lake City, Utah, United States

Site Status

Velocity Clinical Research, Salt Lake City ( Site 0041)

West Jordan, Utah, United States

Site Status

Manassas Clinical Research Center ( Site 0007)

Manassas, Virginia, United States

Site Status

Health Research of Hampton Roads, Inc. ( Site 0019)

Newport News, Virginia, United States

Site Status

Alliance for Multispecialty Research, LLC ( Site 0008)

Norfolk, Virginia, United States

Site Status

National Clinical Research, Inc ( Site 0044)

Richmond, Virginia, United States

Site Status

Rainier Clinical Research Center ( Site 0013)

Renton, Washington, United States

Site Status

CEDIC ( Site 0603)

CABA, Buenos Aires, Argentina

Site Status

Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada ( Site 0605)

CABA, Buenos Aires, Argentina

Site Status

Instituto de Investigaciones Clínicas Mar del Plata ( Site 0602)

Mar del Plata, Buenos Aires, Argentina

Site Status

Instituto de Investigaciones Clinicas Zarate ( Site 0604)

Zárate, Buenos Aires, Argentina

Site Status

Fundacion Estudios Clinicos ( Site 0601)

Rosario, Santa Fe Province, Argentina

Site Status

Centro de Investigaciones Metabolicas CINME - Cardiology ( Site 0607)

CABA, , Argentina

Site Status

CIPREC ( Site 0600)

CABA, , Argentina

Site Status

Fundación Respirar ( Site 0606)

CABA, , Argentina

Site Status

Royal Prince Alfred Hospital-6West CV Ambulatory Care ( Site 2808)

Camperdown, New South Wales, Australia

Site Status

Victorian Heart Hospital-Monash Cardiovascular Research Centre (MCRC) ( Site 2803)

Clayton, Victoria, Australia

Site Status

Universidade Federal Do Ceara ( Site 0702)

Fortaleza, Ceará, Brazil

Site Status

Instituto Dante Pazzanese de Cardiology ( Site 0701)

São Paulo, São Paulo, Brazil

Site Status

Incor - Instituto do Coracao ( Site 0703)

São Paulo, , Brazil

Site Status

The Medical Arts Health Research Group ( Site 0506)

North Vancouver, British Columbia, Canada

Site Status

Cambridge Cardiac Care Centre ( Site 0502)

Cambridge, Ontario, Canada

Site Status

North York Diagnostic and Cardiac Centre ( Site 0505)

North York, Ontario, Canada

Site Status

Ecogene-21 ( Site 0500)

Chicoutimi, Quebec, Canada

Site Status

Institut de Cardiologie de Montreal ( Site 0504)

Montreal, Quebec, Canada

Site Status

Diex Recherche Trois-Rivieres ( Site 0503)

Trois-Rivières, Quebec, Canada

Site Status

Clinical Research Chile SpA ( Site 0800)

Valdivia, Los Ríos Region, Chile

Site Status

CDIEM ( Site 0801)

Providencia, Region M. de Santiago, Chile

Site Status

Pontificia Universidad Catolica de Chile-CICUC ( Site 0803)

Santiago, Region M. de Santiago, Chile

Site Status

Beijing Anzhen Hospital, Capital Medical University-Cardiovascular ( Site 6000)

Beijing, Beijing Municipality, China

Site Status

Beijing Friendship Hospital Affiliate of Capital University ( Site 6003)

Beijing, Beijing Municipality, China

Site Status

The Second Affiliated Hospital of Chongqing Medical University ( Site 6020)

Chongqing, Chongqing Municipality, China

Site Status

Chongqing University Three Gorges Hospital ( Site 6021)

Chongqing, Chongqing Municipality, China

Site Status

Guangdong Provincial People s Hospital ( Site 6004)

Guangzhou, Guangdong, China

Site Status

Zhujiang Hospital ( Site 6029)

Guangzhou, Guangdong, China

Site Status

Huizhou Municipal Central Hospital ( Site 6079)

Huizhou, Guangdong, China

Site Status

The University of Hong Kong-Shenzhen Hospital ( Site 6018)

Shenzhen, Guangdong, China

Site Status

Jingzhou Central Hospital ( Site 6076)

Jingzhou, Hubei, China

Site Status

Wuhan Fourth Hospital ( Site 6056)

Wuhan, Hubei, China

Site Status

Hunan Provincial People's Hospital ( Site 6017)

Changsha, Hunan, China

Site Status

Changzhou Second People's Hospital ( Site 6073)

Changzhou, Jiangsu, China

Site Status

Northern Jiangsu People s Hospital ( Site 6008)

Yangzhou, Jiangsu, China

Site Status

The Third Hospital of Nanchang - Fuhe ( Site 6078)

Nanchang, Jiangxi, China

Site Status

Siping Central People's Hospital ( Site 6011)

Siping, Jilin, China

Site Status

Xianyang Hospital of Yan'an University ( Site 6040)

Xianyang, Shaanxi, China

Site Status

Chengdu Second Municipal People's Hospital ( Site 6032)

Chengdu, Sichuan, China

Site Status

Lishui City People s Hospital ( Site 6002)

Lishui, Zhejiang, China

Site Status

Fundación Centro de Investigación Clínica CIC ( Site 0904)

Medellín, Antioquia, Colombia

Site Status

Ciensalud Ips S A S ( Site 0900)

Barranquilla, Atlántico, Colombia

Site Status

Clinica de la Costa S.A.S. ( Site 0901)

Barranquilla, Atlántico, Colombia

Site Status

Salud SURA Calle 100 ( Site 0905)

Bogotá, Cundinamarca, Colombia

Site Status

Healthy Medical Center S.A.S ( Site 0902)

Zipaquirá, Cundinamarca, Colombia

Site Status

Fundación Valle del Lili ( Site 0903)

Cali, Valle del Cauca Department, Colombia

Site Status

Fakultni Nemocnice u sv. Anny v Brne ( Site 3604)

Brno, Brno-mesto, Czechia

Site Status

Fakultní nemocnice Brno Bohunice-Interni kardiologicka klinika ( Site 3602)

Brno, Brno-mesto, Czechia

Site Status

Institut Klinicke a Experimentalni Mediciny ( Site 3601)

Prague, Praha 4, Czechia

Site Status

Meilahden tornisairaala - Meilahti Tower Hospital ( Site 1300)

Helsinki, Uusimaa, Finland

Site Status

Hôpital Arnaud de Villeneuve - CHU Montpellier ( Site 5002)

Montpellier, Herault, France

Site Status

Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes ( Site 5004)

Saint-Herblain, Loire-Atlantique, France

Site Status

Hospices Civils de Lyon - Hopital Louis Pradel-Service d'endocrinologie, de diabétologie et des mal ( Site 5000)

Bron, Rhone, France

Site Status

Unterfrintroper Hausarztzentrum Klinische Forschung ( Site 1543)

Essen, North Rhine-Westphalia, Germany

Site Status

Universitaetsklinikum Carl Gustav Carus Dresden-Universitätsstudienzentrum für Stoffwechselerkranku ( Site 1510)

Dresden, Saxony, Germany

Site Status

Hausarzt- und Diabetologische Schwerpunktpraxis Hohenmölsen - Weiβenfels ( Site 1528)

Hohenmölsen, Saxony-Anhalt, Germany

Site Status

Zentralklinik Bad Berka ( Site 1531)

Bad Berka, Thuringia, Germany

Site Status

Velocity Clinical Research GmbH Berlin ( Site 1503)

Berlin, , Germany

Site Status

Charite Universitätsmedizin Berlin Campus Benjamin Franklin ( Site 1534)

Berlin, , Germany

Site Status

Queen Mary Hospital-Medical ( Site 3300)

Hksar, , Hong Kong

Site Status

Prince of Wales Hospital ( Site 3304)

Shatin, , Hong Kong

Site Status

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Belgyógyászati Klinika ( Site 1603)

Szeged, Csongrád megye, Hungary

Site Status

Semmelweis Egyetem-Városmajori Szív- és Érgyógyászati Klinika ( Site 1600)

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Anyagcsere Tanszék) ( Site 1601)

Debrecen, , Hungary

Site Status

Hillel Yaffe Medical Center ( Site 1731)

Hadera, , Israel

Site Status

Rambam Health Care Campus ( Site 1739)

Haifa, , Israel

Site Status

Rambam Health Care Campus ( Site 1742)

Haifa, , Israel

Site Status

Shaare Zedek Medical Center ( Site 1735)

Jerusalem, , Israel

Site Status

Hadassah Medical Center ( Site 1732)

Jerusalem, , Israel

Site Status

Hadassah Medical Center ( Site 1741)

Jerusalem, , Israel

Site Status

Hadassah Medical Center-Heart Institute ( Site 1734)

Jerusalem, , Israel

Site Status

Meir Medical Center. ( Site 1737)

Kfar Saba, , Israel

Site Status

Rabin Medical Center ( Site 1738)

Petah Tikva, , Israel

Site Status

Rabin Medical Center ( Site 1740)

Petah Tikva, , Israel

Site Status

Sheba Medical Center ( Site 1733)

Ramat Gan, , Israel

Site Status

Clalit Health Services - Sakhnin Community Clinic ( Site 1730)

Sakhnin, , Israel

Site Status

Yitzhak Shamir Medical Center. ( Site 1736)

Ẕerifin, , Israel

Site Status

Fondazione Policlinico Tor Vergata ( Site 1809)

Rome, Lazio, Italy

Site Status

Centro Cardiologico Monzino ( Site 1804)

Milan, Milano, Italy

Site Status

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino ( Site 1801)

Turin, Piedmont, Italy

Site Status

Azienda Ospedaliera Sant'Andrea-Department of Clinical and Molecular Medicine ( Site 1807)

Rome, Roma, Italy

Site Status

Azienda Ospedaliera Garibaldi ( Site 1810)

Catania, , Italy

Site Status

Hirohata Naika Clinic ( Site 3513)

Kitakyushu, Fukuoka, Japan

Site Status

Nakakinen clinic ( Site 3510)

Naka, Ibaraki, Japan

Site Status

Noritake Clinic ( Site 3512)

Ushiku, Ibaraki, Japan

Site Status

National Hospital Organization Kanazawa Medical Center ( Site 3508)

Kanazawa, Ishikawa-ken, Japan

Site Status

Hirano Medical Clinic ( Site 3522)

Morioka, Iwate, Japan

Site Status

Shirai Healthcare Clinic Izumichuou ( Site 3527)

Sendai, Miyagi, Japan

Site Status

Rinku General Medical Center ( Site 3503)

Izumisano, Osaka, Japan

Site Status

Shiraiwa Medical Clinic ( Site 3514)

Kashihara, Osaka, Japan

Site Status

Medical Corporation Heishinkai OCROM Clinic ( Site 3501)

Suita-shi, Osaka, Japan

Site Status

Saitama Medical University Hospital ( Site 3506)

Iruma, Saitama, Japan

Site Status

Teramoto Medical and Dental Clinic ( Site 3507)

Bunkyo-ku, Tokyo, Japan

Site Status

Tokyo-Eki Center-building Clinic ( Site 3505)

Chuo-ku, Tokyo, Japan

Site Status

Fukuwa Clinic ( Site 3504)

Chuo-ku, Tokyo, Japan

Site Status

Teikyo University Hospital ( Site 3500)

Itabashi-ku, Tokyo, Japan

Site Status

Kato Clinic of Internal Medicine ( Site 3509)

Katsushika-ku, Tokyo, Japan

Site Status

Kanno Naika ( Site 3511)

Mitaka, Tokyo, Japan

Site Status

Sugawara Clinic ( Site 3519)

Nerima-ku, Tokyo, Japan

Site Status

Shin Clinic ( Site 3517)

Ōta-ku, Tokyo, Japan

Site Status

Medical Corporation Heishinkai ToCROM Clinic ( Site 3502)

Shinjuku-ku, Tokyo, Japan

Site Status

Medical Corporation Hakuaikai Wellness Tenjin Clinic ( Site 3520)

Fukuoka, , Japan

Site Status

Hiroshima City Hiroshima Citizens Hospital ( Site 3518)

Hiroshima, , Japan

Site Status

Mishuku Hospital ( Site 3524)

Tokyo, , Japan

Site Status

Mitsukoshi Health and Welfare Foundation ( Site 3521)

Tokyo, , Japan

Site Status

Instituto Jalisciense de Investigacion en Diabetes y Obesidad-Endocrinology ( Site 1057)

Guadalajara, Jalisco, Mexico

Site Status

Instituto Nacional de Ciencias Medicas y Nutricion Salvador -Unidad de Investigación de Enfermedade ( Site 1071)

Mexico City, Mexico City, Mexico

Site Status

Radboudumc-internal medicine ( Site 1952)

Nijmegen, Gelderland, Netherlands

Site Status

Amsterdam UMC, locatie AMC-Vascular Medicine Clin Trial Unit ( Site 1954)

Amsterdam, North Holland, Netherlands

Site Status

Dijklander Ziekenhuis ( Site 1953)

Hoorn, North Holland, Netherlands

Site Status

Universitair Medisch Centrum Utrecht-Vascular Medicine Research ( Site 1955)

Utrecht, , Netherlands

Site Status

Pacific Clinical Research Network - Rotorua ( Site 2902)

Rotorua, Bay of Plenty, New Zealand

Site Status

New Zealand Clinical Research (Christchurch) ( Site 2901)

Christchurch, Canterbury, New Zealand

Site Status

Nordlandssykehuset ( Site 2041)

Bodø, Nordland, Norway

Site Status

Oslo Universitetssykehus Aker-Lipidklinikken ( Site 2040)

Oslo, , Norway

Site Status

Changi General Hospital ( Site 3211)

Singapore, Central Singapore, Singapore

Site Status

IATROS International ( Site 2204)

Bloemfontein, Free State, South Africa

Site Status

Charlotte Maxeke Johannesburg Academic Hospital ( Site 2202)

Johannesburg, Gauteng, South Africa

Site Status

Soweto Clinical Trials Centre ( Site 2203)

Soweto, Gauteng, South Africa

Site Status

TREAD Research ( Site 2201)

Cape Town, Western Cape, South Africa

Site Status

Tiervlei Trial Centre ( Site 2205)

Cape Town, Western Cape, South Africa

Site Status

University of Cape Town (UCT)-Medicine, Division of Lipidology ( Site 2200)

Cape Town, Western Cape, South Africa

Site Status

Wonju Severance Christian Hospital ( Site 3008)

Wŏnju, Kang-won-do, South Korea

Site Status

Chonnam National University Hospital ( Site 3014)

Gwangju, Kwangju-Kwangyokshi, South Korea

Site Status

Seoul National University Bundang Hospital ( Site 3005)

Seongnam, Kyonggi-do, South Korea

Site Status

Ajou University Hospital ( Site 3006)

Suwon, Kyonggi-do, South Korea

Site Status

Chungbuk National University Hospital ( Site 3011)

Cheongju-si, North Chungcheong, South Korea

Site Status

Dong-A University Hospital-Cardiology ( Site 3013)

Busan, Pusan-Kwangyokshi, South Korea

Site Status

Pusan National University Hospital-Internal Medicine ( Site 3012)

Busan, Pusan-Kwangyokshi, South Korea

Site Status

Inje University Haeundae Paik Hospital ( Site 3010)

Haeundae-gu, Pusan-Kwangyokshi, South Korea

Site Status

Keimyung University Dongsan Hospital CRC room 1 ( Site 3003)

Daegu, Taegu-Kwangyokshi, South Korea

Site Status

Seoul National University Hospital ( Site 3001)

Seoul, , South Korea

Site Status

Kangbuk Samsung Hospital ( Site 3009)

Seoul, , South Korea

Site Status

Severance Hospital, Yonsei University Health System ( Site 3002)

Seoul, , South Korea

Site Status

Asan Medical Center ( Site 3004)

Seoul, , South Korea

Site Status

Samsung Medical Center-cardiology ( Site 3000)

Seoul, , South Korea

Site Status

The Catholic Univ. of Korea Seoul St. Mary's Hospital-cardiology ( Site 3007)

Seoul, , South Korea

Site Status

Hospital Universitario Virgen de la Victoria-UGC Endocrinologia y nutricion ( Site 2358)

Málaga, Andalusia, Spain

Site Status

EBA CENTELLES ( Site 2319)

Centelles, Barcelona, Spain

Site Status

Hospital Universitari Vall d'Hebron ( Site 2362)

Barcelona, Catalonia, Spain

Site Status

Hospital de Figueres ( Site 2361)

Figueres, Gerona, Spain

Site Status

Hospital Abente y Lago ( Site 2356)

A Coruña, La Coruna, Spain

Site Status

Hospital San Rafael de Coruna ( Site 2363)

A Coruña, La Coruna, Spain

Site Status

CHUS - Hospital Clinico Universitario-Cardiology - Clinical Research Unit ( Site 2320)

Santiago de Compostela, La Coruna, Spain

Site Status

HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 2344)

Pozuelo de Alarcón, Madrid, Spain

Site Status

Hospital Universitario Fundacion ALcorcon-Endocrinologia y Nutrición ( Site 2316)

Alcorcón, Madrid, Comunidad de, Spain

Site Status

Vithas Hospital Sevilla-Unidad de Salud Metabólica. Diabetes y Obesidad ( Site 2349)

Castilleja de la Cuesta, Sevilla, Spain

Site Status

Hospital Universitari Sant Joan de Reus ( Site 2329)

Reus, Tarragona, Spain

Site Status

HOSPITAL CLINICO DE VALENCIA-CARDIOLOGY ( Site 2321)

Valencia, Valenciana, Comunitat, Spain

Site Status

EAP Sardenya ( Site 2357)

Barcelona, , Spain

Site Status

Hospital Universitario 12 de Octubre-Internal Medicine. Unidad de Ensayos Clínicos ( Site 2311)

Madrid, , Spain

Site Status

Hospital Universitario Virgen Macarena-Cardiology ( Site 2352)

Seville, , Spain

Site Status

Mackay Memorial Hospital -Tamsui Branch ( Site 3109)

New Taipei City, New Taipei, Taiwan

Site Status

Chi Mei Medical Center ( Site 3104)

Tainan City, Tainan, Taiwan

Site Status

Shin Kong Wu Ho-Su Memorial Hospital ( Site 3110)

Taipei City, Taipei, Taiwan

Site Status

Changhua Christian Hospital ( Site 3101)

Changhua, , Taiwan

Site Status

Chang Gung Memorial Hospital at Kaohsiung ( Site 3102)

Kaohsiung City, , Taiwan

Site Status

National Cheng Kung University Hospital-Internal Medicine ( Site 3107)

Tainan City, , Taiwan

Site Status

National Taiwan University Hospital ( Site 3100)

Taipei, , Taiwan

Site Status

Taipei Medical University Hospital ( Site 3108)

Taipei, , Taiwan

Site Status

Taipei Veterans General Hospital ( Site 3106)

Taipei, , Taiwan

Site Status

Chang Gung Medical Foundation-Linkou Branch ( Site 3105)

Taoyuan District, , Taiwan

Site Status

Ege Universitesi Hastanesi-Cardilogy Department ( Site 2502)

Bornova, İzmir, Turkey (Türkiye)

Site Status

Hacettepe Universite Hastaneleri ( Site 2500)

Ankara, , Turkey (Türkiye)

Site Status

Ankara Bilkent Şehir Hastanesi-cardiology ( Site 2501)

Ankara, , Turkey (Türkiye)

Site Status

Eskisehir Osmangazi University-Cardiology ( Site 2510)

Eskişehir, , Turkey (Türkiye)

Site Status

Erciyes Universitesi Tıp Fakultesi Hastaneleri ( Site 2522)

Kayseri, , Turkey (Türkiye)

Site Status

Kocaeli Üniversitesi-Cardiology ( Site 2516)

Kocaeli, , Turkey (Türkiye)

Site Status

Barts Health NHS Trust-William Harvey Clinical Research Centre ( Site 4001)

London, England, United Kingdom

Site Status

Royal Free Hospital ( Site 4000)

London, England, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Brazil Canada Chile China Colombia Czechia Finland France Germany Hong Kong Hungary Israel Italy Japan Mexico Netherlands New Zealand Norway Singapore South Africa South Korea Spain Taiwan Turkey (Türkiye) United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-504922-20-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

U1111-1290-3950

Identifier Type: REGISTRY

Identifier Source: secondary_id

jRCT2051240110

Identifier Type: REGISTRY

Identifier Source: secondary_id

MK-0616-019

Identifier Type: OTHER

Identifier Source: secondary_id

0616-019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MK-0524B Lipid Study (MK-0524B-063)
NCT00479882 COMPLETED PHASE3